Literature DB >> 1665186

Prostaglandin I2 (PGI2) enhances calcium current in guinea-pig ventricular heart cells.

G Alloatti1, L Serazzi, R C Levi.   

Abstract

In the present study we have investigated the electrophysiological effects of two prostaglandins, PGI2 (prostacyclin) and PGE1, in ventricular cells enzymatically isolated from adult guinea pigs, using the whole cell patch-clamp technique. PGI2 (tested in the range 1 nM-10 microM) had marked effects on both action potential and calcium current. The action potential duration and the plateau voltage were enhanced, without any significant modification of the other electrical parameters. In this preparation PGI2 increased the calcium current in a concentration-dependent manner, by up to 60% over the control value (at 10 microM), whereas PGE1 (tested in the range 1 nM-10 microM) had practically no effect on the calcium current. Pretreatment with 10 microM acetylcholine markedly reduced the effect of PGI2 (10 microM). No further increase in the calcium current was induced by PGI2 (5 microM) when the cell was internally perfused with 50 microM cAMP. These data indicate that the positive inotropic effect exerted by PGI2 on cardiac preparations is probably due to enhancement in the calcium current via a cAMP-dependent phosphorylation of the calcium channel.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665186     DOI: 10.1016/0022-2828(91)90218-b

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

1.  Effects of beraprost on the transmembrane potentials of guinea-pig ventricular muscles during normoxia and hypoxia-reoxygenation.

Authors:  Y Ueno; K Shigenobu; S Nishio
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

2.  The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart.

Authors:  M Pavlović; D Petković; M Cvetković; D J Macut; K Zdjelar; M Nesić; O Bosnić; R Radulović; M Mihajlović
Journal:  Experientia       Date:  1995-09-29

3.  cAMP microdomains and L-type Ca2+ channel regulation in guinea-pig ventricular myocytes.

Authors:  Sunita Warrier; Gopalakrishnan Ramamurthy; Richard L Eckert; Viacheslav O Nikolaev; Martin J Lohse; Robert D Harvey
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

4.  A comparative analysis of the time course of cardiac Ca2+ current response to rapid applications of beta-adrenergic and dihydropyridine agonists.

Authors:  P F Méry; A M Frace; H C Hartzell; R Fischmeister
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

5.  M1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes.

Authors:  M P Gallo; G Alloatti; C Eva; A Oberto; R C Levi
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

6.  Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes.

Authors:  D J Church; V Van der Bent; M B Vallotton; U Lang
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

7.  Non-selective cation current of guinea-pig endocardial endothelial cells.

Authors:  K Manabe; M Takano; A Noma
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

8.  In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs.

Authors:  H Oida; T Namba; Y Sugimoto; F Ushikubi; H Ohishi; A Ichikawa; S Narumiya
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Inotropic actions of eicosanoids.

Authors:  K Schrör; T Hohlfeld
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

10.  Protein kinase C-dependent prostaglandin production mediates angiotensin II-induced atrial-natriuretic peptide release.

Authors:  D J Church; S Braconi; V van der Bent; M B Vallotton; U Lang
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.